The choice between thyroidectomy and radioactive iodine (RAI) to treat hyperthyroidism has long been controversial. (Mind, we must not ignore the possibility of remaining long-term on anti-thyroid medication.) The possible side effects of RAI have been described, and discussed, at length over many years - both here in the HU Thyroid UK forum and elsewhere in both professional medical and patient-oriented forums. Side effects of RAI can include:
● A burning sensation or tenderness in the neck area
● Nausea and upset stomach (and rarely, vomiting)
● Swelling and tenderness of the salivary glands
● Taste changes (usually temporary)
● Dry mouth
● Reduction in tear production
● Slightly metallic taste in the mouth, even when not eating, or changes the way certain foods taste.
● Temporary or permanent decreases in blood cell counts can also occur.
● Any person receiving RAI treatment may have a slightly higher risk of developing certain other cancers in the future.
● Lower sperm counts or infertility.
● Irregular periods for up to a year after treatment. Many doctors recommend that women avoid becoming pregnant for at least 6 months to a year after treatment.
To this list, it appears we might need to add an increased risk of cardiovascular diseases.
Of those who have had RAI, were any of you informed of this possibility? (If it had not been known at the time, that might not indicate anyone did anything wrong.)
Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0461. [Epub ahead of print]
Cardiovascular morbidity and mortality after treatment of hyperthyroidism with either radioactive iodine or thyroidectomy.
Ryodi E1, Metso S2, Huhtala H3, Välimäki M4, Auvinen A5, Jaatinen P6,7.
Author information
1 Tampere University Hospital, Heart Hospital, Tampere, Finland ; eryodi@gmail.com.
2 Tampere University Hospital, Department of Internal Medicine, Tampere, Finland ; saara.metso@uta.fi.
3 Tampere University, School of Healt Sciences, Tampere, Finland ; heini.huhtala@uta.fi.
4 Helsinki University Central Hospital, Division of Endocrinology , Tehtaankatu 13 A 25 , Helsinki, Finland , 00140 ; matti.valimaki@horcon.inet.fi.
5 University of Tampere, Faculty of Social Sciences, Tampere, Finland ; anssi.auvinen@uta.fi.
6 University of Tampere, School of Medicine , Building A , Tampere, Finland , FIN-33014.
7 Seinäjoki Central Hospital, Division of Internal Medicine, Seinäjoki, Finland ; pia.jaatinen@uta.fi.
Abstract
BACKGROUND
Hyperthyroid patients remain at an increased risk of cardiovascular diseases (CVDs) after restoring euthyroidism. The impact of the different treatment modalities of hyperthyroidism on future CVD risk remains unclear. The aim of this paper is to assess cardiovascular morbidity and mortality in hyperthyroidism before and after the treatment, and to compare the effects of two different treatment modalities, radioactive iodine (RAI) and thyroid surgery.
METHODS
A comparative cohort study was conducted among 6,148 hyperthyroid patients treated either with RAI or thyroidectomy, and 18,432 age- and gender-matched controls. Firstly, hospitalizations due to CVDs prior to the treatment were analyzed. Secondly, the hazard ratios (HR) for any new hospitalization and mortality due to CVDs after the treatment were estimated among all the hyperthyroid patients compared to the age- and gender-matched controls and also in the RAI-treated patients compared to the thyroidectomy-treated patients. The results were adjusted for prevalent CVDs at the time of treatment.
RESULTS
Before the treatment of hyperthyroidism, hospitalizations due to all CVDs were more common in the hyperthyroid patients compared to the controls (OR 1.61, 95% CI 1.49-1.73). During the post-treatment follow-up, hospitalizations due to CVDs remained more frequent among the patients (HR 1.15, 95% CI 1.09-1.21), but there was no difference in CVD mortality (HR 0.93, 95% CI 0.84-1.03). Compared to the patients treated with thyroidectomy, the RAI-treated patients had a higher risk of hospitalization due to all CVDs (HR 1.17), and atrial fibrillation (HR 1.28), as well as a higher CVD mortality (HR 2.56). Yet, treatment with RAI resulting in hypothyroidism was not associated with increased CVD morbidity compared with thyroidectomy.
CONCLUSIONS
Hyperthyroidism increases the risk of CVD-related hospitalization, and the risk is sustained for up to two decades after treatment with RAI or surgery. Hyperthyroid patients treated with RAI remain at a higher CVD risk compared to patients treated with thyroidectomy. Hypothyroidism during the follow-up, however, predicts better cardiovascular outcome.
PMID: 29882483
DOI: 10.1089/thy.2017.0461